engleski

Guidelines for treatment of pneumonia – are there any changes?

Community-acquired pneumonia has a significant impact on morbidity, mortality, and costs of care. Selected aspects of diagnostics, new scoring systans, importance of niomarkers, resistance problem, role of macrolides and fluoroquinolones, shorter course and switch therapy and prevention are discused.

Communoty-acquired pneumonia; Guidelines; Antibiotics

nije evidentirano